ReAx Biotechnologies

📍 Chicago, United States👥 8 employees💰 Last funded Dec 2021
Biotechnology Research🌐 reaxbio.com
Website LinkedIn
ReAx is a Chicago-based, pre-clinical company that is applying next generation chemical proteomic platforms to discover, optimize and validate small molecules directly in cells. The ReAx pipeline enables interrogation of proteomic ‘dark matter’ – a landscape that is rarely studied, much less exploited for ligand discovery against high-value protein targets. By integrating our platforms with innovative chemistry, disease biology, and computational methods, we hope to deliver first-in-class therapeutics in oncology and immunological disease indications.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in ReAx Biotechnologies?
ReAx Biotechnologies has 2 investors on record on gritt.io.
When did ReAx Biotechnologies last raise funding?
The most recent investment in ReAx Biotechnologies recorded on gritt.io was in December 2021.
What industry is ReAx Biotechnologies in?
ReAx Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ReAx Biotechnologies based?
ReAx Biotechnologies is headquartered in Chicago, United States.